Our current studies show that Smo promoted the accumulation of TP and vice versa, raising the possibility that primary loss of either protein may trigger hepatocyte mitochondrial dysfunction which, in turn, would dysregulate bile acid homeostasis and the gut/liver axis to drive progression of steatotic liver disease. Here, SMO is linked to liver disorder.